Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Steven L. Yoder"'
Publikováno v:
Journal of Antimicrobial Chemotherapy. 41:605-614
Bactericidal activities of clinafloxacin, CI-990 and ciprofloxacin were examined and compared for a small collection of gram-positive and gram-negative pathogens. In-vitro antimicrobial activities were measured by MIC, MBC and time-kill studies; in-v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::158eadec9252fd34b048c3415b2903a3
https://doi.org/10.1093/jac/41.6.605
https://doi.org/10.1093/jac/41.6.605
Publikováno v:
Antimicrobial Agents and Chemotherapy. 39:2123-2127
Certain new fluoroquinolones have high activity against enterococci. Against Enterococcus faecalis (n = 18), MICs at which 90% of the isolates were inhibited were as follows (in micrograms per milliliter): clinafloxacin, 0.125; CI-990, 0.5; and PD 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e00ebbeac14b082f5fd5a8c3c58afbc
https://doi.org/10.1128/aac.39.9.2123
https://doi.org/10.1128/aac.39.9.2123
Autor:
Steven L. Yoder, Carl L. Heifetz, Jeffrey W. Gage, Mark A. Meservey, Sara A. Wold, Michael A. Cohen, Gregory E. Roland, Gail B. Mailloux
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 18:41-47
Cefdinir (FK482), a new oral cephalosporin, displayed potent oral activity versus induced infections in mice. In studies using beta-lactamase-nonproducing (beta LAC-) and -producing (beta LAC+) Staphylococcus aureus strains, respective PD50s (in mg/k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45285becaac42dfd4f8494bda6c1c01c
https://doi.org/10.1016/0732-8893(94)90132-5
https://doi.org/10.1016/0732-8893(94)90132-5
Autor:
Carl L. Heifetz, Steven L. Yoder, Gregory E. Roland, Gail B. Mailloux, Michael A. Cohen, M D Huband
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 14:403-415
Sparfloxacin (CI-978, AT-4140 and PD 131501) is a new antimicrobial agent of the piperazinyl quinolone class. Relative to other quinolones, it is a potent antistaphylococcal and antistreptococcal drug in vitro: The microbroth 90% minimum inhibitory c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e22a4761f22d70d3abd89f9a6ced9df6
https://doi.org/10.1016/0732-8893(91)90067-p
https://doi.org/10.1016/0732-8893(91)90067-p
Autor:
Steven L. Yoder, Gail B. Mailloux, M D Huband, Carl L. Heifetz, Michael A. Cohen, Gregory E. Roland
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 14:245-258
Three new aminopyrrolidine-substituted fluorocyclopropyl quinolones--PD 117596, PD 124816, and PD 127391--were tested for in vitro antibacterial activity against 349 bacterial strains, which are primarily clinical isolates. The minimum inhibitory con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c97d1b240b9b900fbb2437c2bc73e6
https://doi.org/10.1016/0732-8893(91)90039-i
https://doi.org/10.1016/0732-8893(91)90039-i
Autor:
Steven L. Yoder, Gail B. Mailloux, M D Huband, Gregory E. Roland, Carl L. Heifetz, Michael A. Cohen, John M. Domagala
Publikováno v:
Antimicrobial Agents and Chemotherapy. 35:141-146
PD 131628 is a new aminopyrrolidine-substituted fluorocyclopropyl naphthyridine quinolone which possesses high in vitro activity against a wide spectrum of bacterial species. The MICs for greater than or equal to 90% of strains were 0.125 to 0.25 mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8786aba248c106ab35880a92741724
https://doi.org/10.1128/aac.35.1.141
https://doi.org/10.1128/aac.35.1.141
Autor:
Gregory E. Roland, Jeffrey W. Gage, Steven L. Yoder, M D Huband, Stephen J. Gracheck, Michael A. Cohen
Publikováno v:
The Journal of antimicrobial chemotherapy. 40(2)
Clinafloxacin and trovafloxacin are two new fluoroquinolones for which few comparative data are available. When MICs of ciprofloxacin against Gram-positive and Gram-negative nosocomial species were compared, clinafloxacin was the most potent although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f649369cc36515a123194dd4d27883b0
https://pubmed.ncbi.nlm.nih.gov/9301985
https://pubmed.ncbi.nlm.nih.gov/9301985
Autor:
Steven L. Yoder, John M. Domagala, M D Huband, M E Dazer, Michael A. Cohen, Mark A. Meservey, Gregory E. Roland
PD 138312 and PD 140248 are new quinolones with high in vitro activities against a wide spectrum of bacterial species, notably including gram-positive isolates. The respective MICs (in micrograms per milliliter) of PD 138312 and PD 140248 capable of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d128baf33ddf5a898789df650ad0732e
https://europepmc.org/articles/PMC192739/
https://europepmc.org/articles/PMC192739/
